Hours worked
17500 +
Protocols involved
20 +
Sponsors secured
10 +
Департамент клинических исследований
Департамент клинических исследований
Clinical trials department
Why pharmaceutical companies choose us?
Our approach
Four simple steps for a successful clinical trial startClinical trial feasibility study
Ethics assessment
Patient enrollment channels evaluation
Step-by-step trial planning
Our resources
We are all set for conducting top notch clinical trials
"Big Pharma" trust us
If you are interested in a reliable partner for conducting top notch phase II-III clinical trials on a wide range of nosologies and still do not work with us, please contact us
News
Stay up to date
Opening of the center: biological therapy of rheumatoid arthritis
We invite patients with seropositive rheumatoid arthritis of moderate or high degree of disease activity and insufficient response to methotrexate monotherapy to participate in a clinical trial of a new form of tocilizumab
Opening of the Site: HIB-vaccine for children from 3 to 6 months
Recruitment for a clinical trial of a new Russian HIB vaccine for children from 3 to 6 months has begun. The comparison drug is Pentaxime, the placebo group is not assumed. All examination and supervision of a pediatrician is free of charge.
Selection of the Site: a study on the treatment of patients with gastroesophageal reflux disease
Successfully passed a selection visit to participate in a clinical research of a new medicine for the treatment of erosive form of gastroesophageal reflux disease
Our partners
